Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Singapore: A Vibrant Hub for Biomedical Scientists

Published: Friday, December 20, 2013
Last Updated: Friday, December 20, 2013
Bookmark and Share
Ng Siew Kiang, Executive Director for Contact Singapore, discusses the growth of the biomedical sector in Singapore.

Contact Singapore is an alliance of the Singapore Economic Development Board and Ministry of Manpower, which supports professionals and academics from across the globe seeking opportunities to work and live in Singapore. 

Recently, Singapore announced a novel discovery involving the use of nanodiamonds to boost the treatment of chemo-resistant leukaemia. The use of tiny diamonds to facilitate the delivery of drug to leukemic cells was developed by the National University of Singapore (NUS) in partnership with the University of California, Los Angeles (UCLA). In fact, such breakthroughs in areas from cancer and stem cell biology, cardiovascular diseases, diabetes, infectious diseases and neurosciences are commonplace in Singapore. Our research sector is a dynamic, fast-paced environment powered by a community of outstanding scientists and researchers. 

What makes Singapore stand out is our focus on forging collaboration between public and private sector research.  The Biopolis is a shiny beacon of this philosophy. Completed in 2006, this state-of-the-art research facility for biomedical and life sciences houses both public and corporate laboratories, offering unprecedented opportunities for collaboration and the integration of scientific capabilities that has propelled Singapore into a global biomedical sciences hub. 

Another example of knowledge-sharing and communication across different facets of industry is the Academia, an advanced facility which integrates pathology, medical education and research all under the same roof. The 13-storey twin-tower building which opened in July 2013 houses Singapore General Hospital’s pathology services, research laboratories, and education and training facilities of Singapore’s largest healthcare group, SingHealth. 

With such exciting investments come significant opportunities for researchers from all over the world to take up positions in Singapore. 

Singapore has long been at the forefront in supporting and promoting R&D efforts in Asia.  This is demonstrated not only by the calibre of public sector professionals and institutions based here, but also through the government’s active support of private sector research activity from corporate laboratories. 

Already, more than 50 global companies in Singapore are carrying out biomedical sciences R&D, which include drug discovery, translational and clinical research, supported by the government’s commitment to provide £8.3 billion of overall national funding across a range of research disciplines in its latest 5-year master plan ending in 2015.  

Over 6,000 researchers from across the globe currently live and work in Singapore. These companies and individuals have chosen Singapore for its reputation as a vibrant research environment, and because they recognise its potential to grow and develop further in years to come. Aside from a fast-growing research and academic environment, Singapore has a reputation for being one of the world’s most liveable cities, making it an ideal location for overseas professionals looking for a new challenge.

If you’d like to find out more about pursuing career opportunities in Singapore, please visit the link below for more information. 


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,200+ scientific posters on ePosters
  • More than 4,600+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Platelets are the Pathfinders for Leukocyte Extravasation During Inflammation
Findings from the study could help in the prevention and treatment of inflammatory pathologies.
Benchtop Automation Trends
Gain a better understanding of current interest in and future deployment of benchtop automated systems.
Molecular Map Provides Clues To Zinc-Related Diseases
Mapping the molecular structure where medicine goes to work is a crucial step toward drug discovery against deadly diseases.
Genetic Research Can Significantly Improve Drug Development
With drug development costs topping $1.2bn (£850 million) to get a single treatment to the point it can be sold and used in the clinic, could genetic analysis save hundreds of millions of dollars?
New Method Opens Door to Development of Many New Medicines
Findings from TSRI reveal human proteins are better drug targets than previously thought.
Diagnosing Systemic Infections Quickly, Reliably
Team develop rapid and specific diagnostic assay that could help physicians decide within an hour whether a patient has a systemic infection and should be hospitalized for aggressive intervention therapy.
What Makes a Good Scientist?
It’s the journey, not just the destination that counts as a scientist when conducting research.
Blood Test That Detects Early Alzheimer’s Disease
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body’s immune response system to detect an early stage of Alzheimer’s disease – referred to as the mild cognitive impairment (MCI) stage – with unparalleled accuracy.
A New Approach to Chemical Synthesis
Communesins, originally found in fungus, could hold potential as cancer drugs.
Angina Drug Could Inform A New Strategy To Fight Cryptococcosis
A drug, more commonly used in the treatment of angina, could be the focus of a new strategy in fighting the fatal fungal infection cryptococcosis.
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,600+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!